Next Article in Journal
The Role of the Lymph Node Ratio in Advanced Gastric Cancer After Neoadjuvant Chemotherapy
Next Article in Special Issue
Core Binding Factor Leukemia: Chromatin Remodeling Moves Towards Oncogenic Transcription
Previous Article in Journal
Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells
Previous Article in Special Issue
Mutations in Splicing Factor Genes in Myeloid Malignancies: Significance and Impact on Clinical Features
Open AccessReview

Retinoic Acid Receptors in Acute Myeloid Leukemia Therapy

Department of Internal Medicine, Washington University, St Louis, MO 63110, USA
*
Author to whom correspondence should be addressed.
Cancers 2019, 11(12), 1915; https://doi.org/10.3390/cancers11121915
Received: 15 October 2019 / Revised: 26 November 2019 / Accepted: 27 November 2019 / Published: 1 December 2019
(This article belongs to the Special Issue Acute Myeloid Leukemia)
Retinoic acid (RA) signaling pathways regulate fundamental biological processes, such as cell proliferation, development, differentiation, and apoptosis. Retinoid receptors (RARs and RXRs) are ligand-dependent transcription factors. All-trans retinoic acid (ATRA) is the principal endogenous ligand for the retinoic acid receptor alpha (RARA) and is produced by the enzymatic oxidation of dietary vitamin A, whose deficiency is associated with several pathological conditions. Differentiation therapy using ATRA revolutionized the outcome of acute promyelocytic leukemia (APL), although attempts to replicate these results in other cancer types have been met with more modest results. A better knowledge of RA signaling in different leukemia contexts is required to improve initial designs. Here, we will review the RA signaling pathway in normal and malignant hematopoiesis, and will discuss the advantages and the limitations related to retinoid therapy in acute myeloid leukemia.
Keywords: retinoid therapy; APL; AML; ATRA retinoid therapy; APL; AML; ATRA
MDPI and ACS Style

Martino, O.; Welch, J.S. Retinoic Acid Receptors in Acute Myeloid Leukemia Therapy. Cancers 2019, 11, 1915.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop